These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16846230)

  • 1. Solution structure and folding characteristics of the C-terminal SH3 domain of c-Crk-II.
    Muralidharan V; Dutta K; Cho J; Vila-Perello M; Raleigh DP; Cowburn D; Muir TW
    Biochemistry; 2006 Jul; 45(29):8874-84. PubMed ID: 16846230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
    Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
    Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
    Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.
    Zvara A; Fajardo JE; Escalante M; Cotton G; Muir T; Kirsch KH; Birge RB
    Oncogene; 2001 Feb; 20(8):951-61. PubMed ID: 11314030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential SH3 domain-binding site in the Crk SH2 domain.
    Anafi M; Rosen MK; Gish GD; Kay LE; Pawson T
    J Biol Chem; 1996 Aug; 271(35):21365-74. PubMed ID: 8702917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
    McDonald CB; Seldeen KL; Deegan BJ; Farooq A
    Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution NMR structure and ligand identification of human Gas7 SH3 domain reveal a typical SH3 fold but a non-canonical ligand-binding mode.
    Nie Y; Zhu J; Ramelot TA; Kennedy MA; Liu M; He T; Yang Y
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1190-1195. PubMed ID: 31296381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structure of the Src family kinase Hck SH3-SH2 linker regulatory region supports an SH3-dominant activation mechanism.
    Alvarado JJ; Betts L; Moroco JA; Smithgall TE; Yeh JI
    J Biol Chem; 2010 Nov; 285(46):35455-61. PubMed ID: 20810664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct binding of C-terminal region of p130Cas to SH2 and SH3 domains of Src kinase.
    Nakamoto T; Sakai R; Ozawa K; Yazaki Y; Hirai H
    J Biol Chem; 1996 Apr; 271(15):8959-65. PubMed ID: 8621540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
    Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
    J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iterative tyrosine phosphorylation controls non-canonical domain utilization in Crk.
    Sriram G; Jankowski W; Kasikara C; Reichman C; Saleh T; Nguyen KQ; Li J; Hornbeck P; Machida K; Liu T; Li H; Kalodimos CG; Birge RB
    Oncogene; 2015 Aug; 34(32):4260-9. PubMed ID: 25381819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of Abl SH3, and its relationship to SH2 in the SH(32) construct.
    Gosser YQ; Zheng J; Overduin M; Mayer BJ; Cowburn D
    Structure; 1995 Oct; 3(10):1075-86. PubMed ID: 8590002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins.
    Tanaka M; Gupta R; Mayer BJ
    Mol Cell Biol; 1995 Dec; 15(12):6829-37. PubMed ID: 8524249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: The carboxyl-terminal Crk SH3 domain: Regulatory strategies and new perspectives.
    Sriram G; Birge RB
    FEBS Lett; 2012 Aug; 586(17):2615-8. PubMed ID: 22710158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proline-rich sequences mediate the interaction of the Arg protein tyrosine kinase with Crk.
    Wang B; Mysliwiec T; Feller SM; Knudsen B; Hanafusa H; Kruh GD
    Oncogene; 1996 Oct; 13(7):1379-85. PubMed ID: 8875975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
    Wu X; Knudsen B; Feller SM; Zheng J; Sali A; Cowburn D; Hanafusa H; Kuriyan J
    Structure; 1995 Feb; 3(2):215-26. PubMed ID: 7735837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.
    Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA
    J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SH3 domain of a M7 interacts with its C-terminal proline-rich region.
    Wang Q; Deloia MA; Kang Y; Litchke C; Zhang N; Titus MA; Walters KJ
    Protein Sci; 2007 Feb; 16(2):189-96. PubMed ID: 17189480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.